Final Results of Study of Loncastuximab Tesirine in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Final Results of a Phase 1 Study of Loncastuximab Tesirine in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Blood 2020 Nov 19;[EPub Ahead of Print], M Hamadani, J Radford, C Carlo-Stella, PF Caimi, EG Reid, OA O'Connor, J Feingold, KM Ardeshna, WM Townsend, M Solh, LT Heffner, D Ungar, L Wang, JP Boni, K Havenith, YG Qin, B KahlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.